Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
RARE
↓ PDF (Pro)Ultragenyx Pharmaceutical Inc. Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$26.10
+4.36%today
MKT CAP
$2.6B
+6.6% · 1Y
Earnings History
+4.4%
+11.4%
-49.7%
-10.1%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$26.10
Low
$25.00
Analyst Mean
$53.35
High
$84.00
20 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E147.2x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-34.3%
5y Revenue CAGR+22.8%
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership3.4%
Institutional Ownership98.9%
Short % of Float12.72%
Days to Cover5.8d
1 Week-0.1%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| HORN HOWARD | Chief Financial Officer | Sale | 4,683 | $24.90 | $0.12M | 2026-05-01 |
| HUIZENGA THEODORE ALAN | Officer | Stock | 20,241 | $0.00 | $0.00M | 2026-04-22 |
| KAKKIS EMIL D | Chief Executive Officer | Stock | 76,745 | $0.00 | $0.00M | 2026-04-16 |
| HUANG DENNIS KARL | Chief Technology Officer | Stock | 23,116 | $0.00 | $0.00M | 2026-04-16 |
| PINION JOHN RICHARD | Officer | Stock | 23,116 | $0.00 | $0.00M | 2026-04-16 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Vanguard Group Inc | institution | 10.44% | $0.27B | +1.29% | 2025-12-31 |
| Blackrock Inc. | institution | 6.75% | $0.17B | +3.21% | 2025-12-31 |
| State Street Corporation | institution | 4.38% | $0.11B | +16.54% | 2025-12-31 |
| JPMORGAN CHASE & CO | institution | 4.04% | $0.10B | -50.47% | 2025-12-31 |
| Sands Capital Management, LLC | institution | 3.55% | $0.09B | -7.54% | 2025-12-31 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | fund | 3.31% | $0.09B | +23.60% | 2026-03-31 |
| RTW Investments LP | institution | 3.05% | $0.08B | -7.92% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 2.94% | $0.08B | +2.30% | 2025-12-31 |
| Baker Bros. Advisors, LP | institution | 2.82% | $0.07B | +0.00% | 2025-12-31 |
| FMR, LLC | institution | 2.71% | $0.07B | -63.39% | 2025-12-31 |
| Wellington Management Group, LLP | institution | 2.50% | $0.06B | +26.57% | 2025-12-31 |
| Citadel Advisors Llc | institution | 2.37% | $0.06B | +602.86% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | fund | 2.11% | $0.05B | -4.22% | 2025-12-31 |
| Vanguard Explorer Fund | fund | 1.75% | $0.04B | +12.39% | 2026-01-31 |
| JPMorgan Trust II-JPMorgan Mid Cap Growth Fund | fund | 1.62% | $0.04B | -2.29% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | fund | 1.19% | $0.03B | -3.23% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 1.06% | $0.03B | +1.57% | 2025-12-31 |
| abrdn Healthcare Investors | fund | 0.95% | $0.02B | +49.69% | 2025-12-31 |
| VANGUARD HORIZON FUNDS-Vanguard Strategic Equity Fund | fund | 0.80% | $0.02B | +0.00% | 2025-12-31 |
| Touchstone Fd.s Group TRT-Touchstone Fd.s Group TRT-Touchstone Sands C | fund | 0.70% | $0.02B | -4.61% | 2025-12-31 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for RARE.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.